Insulin Patch-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Insulin Patch-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Insulin Patch industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Insulin Patch 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Insulin Patch worldwide and market share by regions, with company and product introduction, position in the Insulin Patch market
Market status and development trend of Insulin Patch by types and applications
Cost and profit status of Insulin Patch, and marketing status
Market growth drivers and challenges
The report segments the global Insulin Patch market as:
Global Insulin Patch Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Insulin Patch Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Insulin Patch for Diabete
Insulin Patch for Diabete
Others
Global Insulin Patch Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Retail pharmacies
Private clinics
Online pharmacies
Global Insulin Patch Market: Manufacturers Segment Analysis (Company and Product introduction, Insulin Patch Sales Volume, Revenue, Price and Gross Margin):
Dermisonics
Encapsulation Systems
Encapsulife
Mesoblast
NeurogesX
NOLabs AB
Novo Nordisk
Phosphagenics
Relmada Therapeutics
Zosano Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Insulin Patch-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Insulin Patch industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Insulin Patch 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Insulin Patch worldwide and market share by regions, with company and product introduction, position in the Insulin Patch market
Market status and development trend of Insulin Patch by types and applications
Cost and profit status of Insulin Patch, and marketing status
Market growth drivers and challenges
The report segments the global Insulin Patch market as:
Global Insulin Patch Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Insulin Patch Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Insulin Patch for Diabete
Insulin Patch for Diabete
Others
Global Insulin Patch Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Retail pharmacies
Private clinics
Online pharmacies
Global Insulin Patch Market: Manufacturers Segment Analysis (Company and Product introduction, Insulin Patch Sales Volume, Revenue, Price and Gross Margin):
Dermisonics
Encapsulation Systems
Encapsulife
Mesoblast
NeurogesX
NOLabs AB
Novo Nordisk
Phosphagenics
Relmada Therapeutics
Zosano Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INSULIN PATCH
1.1 Definition of Insulin Patch in This Report
1.2 Commercial Types of Insulin Patch
1.2.1 Insulin Patch for Diabete
1.2.2 Insulin Patch for Diabete
1.2.3 Others
1.3 Downstream Application of Insulin Patch
1.3.1 Hospitals
1.3.2 Retail pharmacies
1.3.3 Private clinics
1.3.4 Online pharmacies
1.4 Development History of Insulin Patch
1.5 Market Status and Trend of Insulin Patch 2013-2023
1.5.1 Global Insulin Patch Market Status and Trend 2013-2023
1.5.2 Regional Insulin Patch Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Insulin Patch 2013-2017
2.2 Sales Market of Insulin Patch by Regions
2.2.1 Sales Volume of Insulin Patch by Regions
2.2.2 Sales Value of Insulin Patch by Regions
2.3 Production Market of Insulin Patch by Regions
2.4 Global Market Forecast of Insulin Patch 2018-2023
2.4.1 Global Market Forecast of Insulin Patch 2018-2023
2.4.2 Market Forecast of Insulin Patch by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Insulin Patch by Types
3.2 Sales Value of Insulin Patch by Types
3.3 Market Forecast of Insulin Patch by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Insulin Patch by Downstream Industry
4.2 Global Market Forecast of Insulin Patch by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Insulin Patch Market Status by Countries
5.1.1 North America Insulin Patch Sales by Countries (2013-2017)
5.1.2 North America Insulin Patch Revenue by Countries (2013-2017)
5.1.3 United States Insulin Patch Market Status (2013-2017)
5.1.4 Canada Insulin Patch Market Status (2013-2017)
5.1.5 Mexico Insulin Patch Market Status (2013-2017)
5.2 North America Insulin Patch Market Status by Manufacturers
5.3 North America Insulin Patch Market Status by Type (2013-2017)
5.3.1 North America Insulin Patch Sales by Type (2013-2017)
5.3.2 North America Insulin Patch Revenue by Type (2013-2017)
5.4 North America Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Insulin Patch Market Status by Countries
6.1.1 Europe Insulin Patch Sales by Countries (2013-2017)
6.1.2 Europe Insulin Patch Revenue by Countries (2013-2017)
6.1.3 Germany Insulin Patch Market Status (2013-2017)
6.1.4 UK Insulin Patch Market Status (2013-2017)
6.1.5 France Insulin Patch Market Status (2013-2017)
6.1.6 Italy Insulin Patch Market Status (2013-2017)
6.1.7 Russia Insulin Patch Market Status (2013-2017)
6.1.8 Spain Insulin Patch Market Status (2013-2017)
6.1.9 Benelux Insulin Patch Market Status (2013-2017)
6.2 Europe Insulin Patch Market Status by Manufacturers
6.3 Europe Insulin Patch Market Status by Type (2013-2017)
6.3.1 Europe Insulin Patch Sales by Type (2013-2017)
6.3.2 Europe Insulin Patch Revenue by Type (2013-2017)
6.4 Europe Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Insulin Patch Market Status by Countries
7.1.1 Asia Pacific Insulin Patch Sales by Countries (2013-2017)
7.1.2 Asia Pacific Insulin Patch Revenue by Countries (2013-2017)
7.1.3 China Insulin Patch Market Status (2013-2017)
7.1.4 Japan Insulin Patch Market Status (2013-2017)
7.1.5 India Insulin Patch Market Status (2013-2017)
7.1.6 Southeast Asia Insulin Patch Market Status (2013-2017)
7.1.7 Australia Insulin Patch Market Status (2013-2017)
7.2 Asia Pacific Insulin Patch Market Status by Manufacturers
7.3 Asia Pacific Insulin Patch Market Status by Type (2013-2017)
7.3.1 Asia Pacific Insulin Patch Sales by Type (2013-2017)
7.3.2 Asia Pacific Insulin Patch Revenue by Type (2013-2017)
7.4 Asia Pacific Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Insulin Patch Market Status by Countries
8.1.1 Latin America Insulin Patch Sales by Countries (2013-2017)
8.1.2 Latin America Insulin Patch Revenue by Countries (2013-2017)
8.1.3 Brazil Insulin Patch Market Status (2013-2017)
8.1.4 Argentina Insulin Patch Market Status (2013-2017)
8.1.5 Colombia Insulin Patch Market Status (2013-2017)
8.2 Latin America Insulin Patch Market Status by Manufacturers
8.3 Latin America Insulin Patch Market Status by Type (2013-2017)
8.3.1 Latin America Insulin Patch Sales by Type (2013-2017)
8.3.2 Latin America Insulin Patch Revenue by Type (2013-2017)
8.4 Latin America Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Insulin Patch Market Status by Countries
9.1.1 Middle East and Africa Insulin Patch Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Insulin Patch Revenue by Countries (2013-2017)
9.1.3 Middle East Insulin Patch Market Status (2013-2017)
9.1.4 Africa Insulin Patch Market Status (2013-2017)
9.2 Middle East and Africa Insulin Patch Market Status by Manufacturers
9.3 Middle East and Africa Insulin Patch Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Insulin Patch Sales by Type (2013-2017)
9.3.2 Middle East and Africa Insulin Patch Revenue by Type (2013-2017)
9.4 Middle East and Africa Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF INSULIN PATCH
10.1 Global Economy Situation and Trend Overview
10.2 Insulin Patch Downstream Industry Situation and Trend Overview
CHAPTER 11 INSULIN PATCH MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Insulin Patch by Major Manufacturers
11.2 Production Value of Insulin Patch by Major Manufacturers
11.3 Basic Information of Insulin Patch by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Insulin Patch Major Manufacturer
11.3.2 Employees and Revenue Level of Insulin Patch Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 INSULIN PATCH MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Dermisonics
12.1.1 Company profile
12.1.2 Representative Insulin Patch Product
12.1.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Dermisonics
12.2 Encapsulation Systems
12.2.1 Company profile
12.2.2 Representative Insulin Patch Product
12.2.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Encapsulation Systems
12.3 Encapsulife
12.3.1 Company profile
12.3.2 Representative Insulin Patch Product
12.3.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Encapsulife
12.4 Mesoblast
12.4.1 Company profile
12.4.2 Representative Insulin Patch Product
12.4.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Mesoblast
12.5 NeurogesX
12.5.1 Company profile
12.5.2 Representative Insulin Patch Product
12.5.3 Insulin Patch Sales, Revenue, Price and Gross Margin of NeurogesX
12.6 NOLabs AB
12.6.1 Company profile
12.6.2 Representative Insulin Patch Product
12.6.3 Insulin Patch Sales, Revenue, Price and Gross Margin of NOLabs AB
12.7 Novo Nordisk
12.7.1 Company profile
12.7.2 Representative Insulin Patch Product
12.7.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Novo Nordisk
12.8 Phosphagenics
12.8.1 Company profile
12.8.2 Representative Insulin Patch Product
12.8.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Phosphagenics
12.9 Relmada Therapeutics
12.9.1 Company profile
12.9.2 Representative Insulin Patch Product
12.9.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Relmada Therapeutics
12.10 Zosano Pharma
12.10.1 Company profile
12.10.2 Representative Insulin Patch Product
12.10.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Zosano Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN PATCH
13.1 Industry Chain of Insulin Patch
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF INSULIN PATCH
14.1 Cost Structure Analysis of Insulin Patch
14.2 Raw Materials Cost Analysis of Insulin Patch
14.3 Labor Cost Analysis of Insulin Patch
14.4 Manufacturing Expenses Analysis of Insulin Patch
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Insulin Patch in This Report
1.2 Commercial Types of Insulin Patch
1.2.1 Insulin Patch for Diabete
1.2.2 Insulin Patch for Diabete
1.2.3 Others
1.3 Downstream Application of Insulin Patch
1.3.1 Hospitals
1.3.2 Retail pharmacies
1.3.3 Private clinics
1.3.4 Online pharmacies
1.4 Development History of Insulin Patch
1.5 Market Status and Trend of Insulin Patch 2013-2023
1.5.1 Global Insulin Patch Market Status and Trend 2013-2023
1.5.2 Regional Insulin Patch Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Insulin Patch 2013-2017
2.2 Sales Market of Insulin Patch by Regions
2.2.1 Sales Volume of Insulin Patch by Regions
2.2.2 Sales Value of Insulin Patch by Regions
2.3 Production Market of Insulin Patch by Regions
2.4 Global Market Forecast of Insulin Patch 2018-2023
2.4.1 Global Market Forecast of Insulin Patch 2018-2023
2.4.2 Market Forecast of Insulin Patch by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Insulin Patch by Types
3.2 Sales Value of Insulin Patch by Types
3.3 Market Forecast of Insulin Patch by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Insulin Patch by Downstream Industry
4.2 Global Market Forecast of Insulin Patch by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Insulin Patch Market Status by Countries
5.1.1 North America Insulin Patch Sales by Countries (2013-2017)
5.1.2 North America Insulin Patch Revenue by Countries (2013-2017)
5.1.3 United States Insulin Patch Market Status (2013-2017)
5.1.4 Canada Insulin Patch Market Status (2013-2017)
5.1.5 Mexico Insulin Patch Market Status (2013-2017)
5.2 North America Insulin Patch Market Status by Manufacturers
5.3 North America Insulin Patch Market Status by Type (2013-2017)
5.3.1 North America Insulin Patch Sales by Type (2013-2017)
5.3.2 North America Insulin Patch Revenue by Type (2013-2017)
5.4 North America Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Insulin Patch Market Status by Countries
6.1.1 Europe Insulin Patch Sales by Countries (2013-2017)
6.1.2 Europe Insulin Patch Revenue by Countries (2013-2017)
6.1.3 Germany Insulin Patch Market Status (2013-2017)
6.1.4 UK Insulin Patch Market Status (2013-2017)
6.1.5 France Insulin Patch Market Status (2013-2017)
6.1.6 Italy Insulin Patch Market Status (2013-2017)
6.1.7 Russia Insulin Patch Market Status (2013-2017)
6.1.8 Spain Insulin Patch Market Status (2013-2017)
6.1.9 Benelux Insulin Patch Market Status (2013-2017)
6.2 Europe Insulin Patch Market Status by Manufacturers
6.3 Europe Insulin Patch Market Status by Type (2013-2017)
6.3.1 Europe Insulin Patch Sales by Type (2013-2017)
6.3.2 Europe Insulin Patch Revenue by Type (2013-2017)
6.4 Europe Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Insulin Patch Market Status by Countries
7.1.1 Asia Pacific Insulin Patch Sales by Countries (2013-2017)
7.1.2 Asia Pacific Insulin Patch Revenue by Countries (2013-2017)
7.1.3 China Insulin Patch Market Status (2013-2017)
7.1.4 Japan Insulin Patch Market Status (2013-2017)
7.1.5 India Insulin Patch Market Status (2013-2017)
7.1.6 Southeast Asia Insulin Patch Market Status (2013-2017)
7.1.7 Australia Insulin Patch Market Status (2013-2017)
7.2 Asia Pacific Insulin Patch Market Status by Manufacturers
7.3 Asia Pacific Insulin Patch Market Status by Type (2013-2017)
7.3.1 Asia Pacific Insulin Patch Sales by Type (2013-2017)
7.3.2 Asia Pacific Insulin Patch Revenue by Type (2013-2017)
7.4 Asia Pacific Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Insulin Patch Market Status by Countries
8.1.1 Latin America Insulin Patch Sales by Countries (2013-2017)
8.1.2 Latin America Insulin Patch Revenue by Countries (2013-2017)
8.1.3 Brazil Insulin Patch Market Status (2013-2017)
8.1.4 Argentina Insulin Patch Market Status (2013-2017)
8.1.5 Colombia Insulin Patch Market Status (2013-2017)
8.2 Latin America Insulin Patch Market Status by Manufacturers
8.3 Latin America Insulin Patch Market Status by Type (2013-2017)
8.3.1 Latin America Insulin Patch Sales by Type (2013-2017)
8.3.2 Latin America Insulin Patch Revenue by Type (2013-2017)
8.4 Latin America Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Insulin Patch Market Status by Countries
9.1.1 Middle East and Africa Insulin Patch Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Insulin Patch Revenue by Countries (2013-2017)
9.1.3 Middle East Insulin Patch Market Status (2013-2017)
9.1.4 Africa Insulin Patch Market Status (2013-2017)
9.2 Middle East and Africa Insulin Patch Market Status by Manufacturers
9.3 Middle East and Africa Insulin Patch Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Insulin Patch Sales by Type (2013-2017)
9.3.2 Middle East and Africa Insulin Patch Revenue by Type (2013-2017)
9.4 Middle East and Africa Insulin Patch Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF INSULIN PATCH
10.1 Global Economy Situation and Trend Overview
10.2 Insulin Patch Downstream Industry Situation and Trend Overview
CHAPTER 11 INSULIN PATCH MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Insulin Patch by Major Manufacturers
11.2 Production Value of Insulin Patch by Major Manufacturers
11.3 Basic Information of Insulin Patch by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Insulin Patch Major Manufacturer
11.3.2 Employees and Revenue Level of Insulin Patch Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 INSULIN PATCH MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Dermisonics
12.1.1 Company profile
12.1.2 Representative Insulin Patch Product
12.1.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Dermisonics
12.2 Encapsulation Systems
12.2.1 Company profile
12.2.2 Representative Insulin Patch Product
12.2.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Encapsulation Systems
12.3 Encapsulife
12.3.1 Company profile
12.3.2 Representative Insulin Patch Product
12.3.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Encapsulife
12.4 Mesoblast
12.4.1 Company profile
12.4.2 Representative Insulin Patch Product
12.4.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Mesoblast
12.5 NeurogesX
12.5.1 Company profile
12.5.2 Representative Insulin Patch Product
12.5.3 Insulin Patch Sales, Revenue, Price and Gross Margin of NeurogesX
12.6 NOLabs AB
12.6.1 Company profile
12.6.2 Representative Insulin Patch Product
12.6.3 Insulin Patch Sales, Revenue, Price and Gross Margin of NOLabs AB
12.7 Novo Nordisk
12.7.1 Company profile
12.7.2 Representative Insulin Patch Product
12.7.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Novo Nordisk
12.8 Phosphagenics
12.8.1 Company profile
12.8.2 Representative Insulin Patch Product
12.8.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Phosphagenics
12.9 Relmada Therapeutics
12.9.1 Company profile
12.9.2 Representative Insulin Patch Product
12.9.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Relmada Therapeutics
12.10 Zosano Pharma
12.10.1 Company profile
12.10.2 Representative Insulin Patch Product
12.10.3 Insulin Patch Sales, Revenue, Price and Gross Margin of Zosano Pharma
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN PATCH
13.1 Industry Chain of Insulin Patch
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF INSULIN PATCH
14.1 Cost Structure Analysis of Insulin Patch
14.2 Raw Materials Cost Analysis of Insulin Patch
14.3 Labor Cost Analysis of Insulin Patch
14.4 Manufacturing Expenses Analysis of Insulin Patch
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
